Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
1.05
+0.04 (3.86%)
Aug 12, 2022 2:49 PM EDT - Market open
Ratios and Metrics (Quarterly)
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Quarter Ended | Current | 2022-04-30 | 2022-01-31 | 2021-10-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Market Capitalization
|
100 | 92 | 136 | 186 | 377 |
| Enterprise Value
|
86 | 78 | 124 | 173 | 362 |
| PE Ratio
|
- | -7.43 | -13.94 | -22.41 | -62.39 |
| PB Ratio
|
7.50 | 6.88 | 11.36 | 14.28 | 24.60 |
| Debt / Equity Ratio
|
- | 0 | 0 | 0.03 | 0.02 |
| Current Ratio
|
12.37 | 12.37 | 26.62 | 9.83 | 11.41 |
| Buyback Yield / Dilution
|
-22.64% | -19.12% | -30.31% | -29.33% | -17.06% |
| Total Shareholder Return
|
-22.64% | -19.12% | -30.31% | -29.33% | -17.06% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).